Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study

Charly Hélaine(Centre National de la Recherche Scientifique), Edwige Petit(Centre National de la Recherche Scientifique)

Cancers

November 30, 2020

10.3390/cancers12123585

Cited by 6

Related Papers

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

|Oncotarget|2014|35